RFA-CA-22-004 - Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

Expired NOSIs

Title Notice Number Organization Release Date Expiration Date Activity Code(s)
Notice of Special Interest (NOSI): Technologies and Informatics Tools for Cancer Metabolomics NOT-CA-22-083 NCI Apr 26, 2022 Dec 31, 2024 R33, R61, R21, U24, U01

For technical issues E-mail OER Webmaster